Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-14

Clinical Trial Update: Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing fractional radiofrequency with topical tretinoin for treating striae distensae has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRETINOIN (TRETINOIN)
  • fractional radiofrequency

Snippet

Sponsor: Merete Haedersdal | Conditions: Striae Distensae | Phase 2 | Status: COMPLETED